LumibirdHAM:QTL -3.93%65 EV-to-FCF is 48.31 as of Jun. 25, 2026, which is 28% above its 10-year median of 37.71. GuruFocus rates HAM:QTL with a GF Score™ of 65/100 and a GF Value™ of €16.31 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Lumibird ranks worse than 76.53% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lumibird's Enterprise Value is €610.9 Mil.
Lumibird's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €12.6 Mil. Therefore, Lumibird's EV-to-FCF for today is 48.31.
The historical rank and industry rank for Lumibird's EV-to-FCF or its related term are showing as below:
HAM:QTL'
s EV-to-FCF Range Over the Past 10 Years
Min: -82.99 Med: 37.71 Max: 716.76
Current: 49.71
During the past 13 years, the highest EV-to-FCF of Lumibird was 716.76. The lowest was -82.99. And the median was 37.71.
HAM:QTL's EV-to-FCF is ranked worse than 76.53% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.535
vs HAM:QTL: 49.71
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Lumibird's share price for today is €23.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumibird's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Lumibird EV-to-FCF Related Terms
Lumibird EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Lumibird's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Lumibird's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumibird EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Lumibird's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Lumibird's EV-to-FCF falls into.
Lumibird's current Enterprise Value is €610.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumibird's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €12.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumibird (HAM:QTL) has a EV-to-FCF of 48.31 as of Jun. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Lumibird and its competitors. This is 28% above median its historical median of 37.71. According to the industry distribution chart, Lumibird ranks #75 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 76.5%.
Is Lumibird's EV-to-FCF too high?
Lumibird's current EV-to-FCF of 48.31 is 28% above median its 10-year median of 37.71. The Medical Diagnostics & Research industry median EV-to-FCF is 22.54. Lumibird's value of 48.31 is 114.4% above this industry median. Based on the distribution chart, Lumibird ranks #75 out of 98 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Lumibird has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lumibird's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Lumibird ranks #75 out of 98 companies for EV-to-FCF. This places Lumibird in the lower half of its industry. The industry median EV-to-FCF is 22.54. Lumibird's value of 48.31 is 114.4% above this benchmark. While the company's 10-year median is 37.71 vs. the industry median of 22.54, Lumibird has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.54, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumibird's current EV-to-FCF of 48.31 is 114.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Lumibird and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumibird's current EV-to-FCF is 48.31, which is 28% above median its own 10-year median of 37.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumibird stock overvalued right now?
Based on GuruFocus' analysis, Lumibird (HAM:QTL) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.31, compared to a current price of €23.25 — trading 42.6% above its estimated fair value. The current EV-to-FCF is 48.31, which is 28% above median its 10-year median of 37.71 and 114.4% above the Medical Diagnostics & Research industry median of 22.54. Lumibird's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Lumibird (HAM:QTL), the current EV-to-FCF is 48.31 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lumibird (HAM:QTL) Overvalued in 2026?
Based on GuruFocus' analysis, Lumibird stock appears to be overvalued.
The current stock price of €23.25 is trading 42.6% above its estimated GF Value™ of €16.31.
GuruFocus considers Lumibird to be Significantly Overvalued.
Key valuation signals for HAM:QTL:
EV-to-FCF: 48.31 (28% above median its 10-year median of 37.71)
GF Value™: €16.31 vs. price of €23.25 (42.6% above fair value)
Industry Position: 114.4% above the Medical Diagnostics & Research median (#75 of 98)
No single metric tells the full story. See the HAM:QTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.
65GF Score
Get the complete analysis for HAM:QTL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:QTL has been successfully added to your 
